Cardiovascular disease remains the #1 killer in the developed world. Loss of cardiomyocytes due to myocardial infarction or chronic apoptosis can lead to heart failure, affecting more than 23 million people worldwide. We currently lack a nuanced understanding of how the mechanisms of dysfunction of heart disease are linked to contractile phenotypes at the protein, sarcomere and cellular levels. Unfortunately, the scarcity of human heart tissue and the inability to maintain mature, primary cardiomyocytes in vitro has hindered investigation of the basic mechanisms of cardiotoxicity and human heart disease and physiology of cardiomyocytes. Conversely, human induced pluripotent stem cell-derived cardiomyocytes are readily available (even commercially), can be maintained for months in culture, and frozen for future use. A crucial motivation for this work is the divergence between human cardiomyocytes and animal model cardiomyocytes in physiology, structural composition, and fundamental biology. These differences are particularly acute when screening cardiotoxicity of drugs or treatments for use in humans. Human induced pluripotent stem cell-derived cardiomyocytes seem to hold great promise in this regard, but current protocols for deriving cells yield heterogeneous populations in terms of structure, function, contractility, and other crucial parameters. In this application, we seek to establish a high-risk, high-reward paradigm shift: that quantitative analysis of myofibril organization in engineered single cardiomyocytes with physiological shape and sarcomere organization will empower researchers to overcome the heterogeneities observed in human induced pluripotent stem cell-derived cardiomyocyte populations, positioning the contractile behavior and myofibril organization of human induced pluripotent stem cell-derived cardiomyocyte as models of cardiotoxicity and diseases of the myocardium (cardiomyopathies). We will engineer the morphology and subcellular myofibril alignment of human induced pluripotent stem cell-derived cardiomyocytes through their interface with mechanically tuned cell culture environments. By providing in situ non-destructive functional assessment, while driving maturity in single iPSC-cardiomyocytes, we will enable quantitative studies of contractility, work and power in terminally differentiated cardiomyocytes. These models of matured stem cell-derived cardiomyocytes also have the potential to avoid the problems of poor long-term survival of primary cardiomyocyte models in vitro, to reduce our reliance on animal models and to avoid their known differences from human cells. Our proposed project provides methods and systems for sustaining stem cell-derived cardiomyocytes in biomimetic culture conditions along with non-destructive contractility assays required to assess the function of these cells before and after interventions to rescue healthy phenotypes. We further aim to deploy these model systems and methods to characterize the biophysics of mutations causing heritable cardiomyopathies. We seek to demonstrate models suitable for future translation towards high- throughput testing of therapies with patient specificity.
Heart disease remains the number one killer in the developed world, yet the link between cardiac and heart muscle cell dysfunction due to subcellular defects remains poorly understood in large part because human and animal model physiology differ at the cellular level. By engineering individual heart muscle cells differentiate from induced pluripotent stem cells, we explore the potential to use human cells as screen therapies for cardiotoxicity and to reveal basic mechanisms of heart muscle function at the sarcomere level in disease. This work delivers new model systems and methods to functionally assess human cardiomyocytes, the fundamental motor unit of heart function, and addresses a bottleneck in testing targeted interventions for heart disease and researching its pathophysiological mechanisms.
| Kim, Anna A; Nekimken, Adam L; Fechner, Sylvia et al. (2018) Microfluidics for mechanobiology of model organisms. Methods Cell Biol 146:217-259 |
| Ribeiro, Alexandre J S; Schwab, Olivier; Mandegar, Mohammad A et al. (2017) Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes. Circ Res 120:1572-1583 |
| Ang, Yen-Sin; Rivas, Renee N; Ribeiro, Alexandre J S et al. (2016) Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis. Cell 167:1734-1749.e22 |
| Chang, Alice C; Mekhdjian, Armen H; Morimatsu, Masatoshi et al. (2016) Single Molecule Force Measurements in Living Cells Reveal a Minimally Tensioned Integrin State. ACS Nano 10:10745-10752 |
